References
Gadkowski LB, Stout JE (2008) Cavitary pulmonary disease. Clin Microbiol Rev 21:305–333
Surowiec D, DePestel DD, Carver PL (2008) Concurrent administration of sirolimus and voriconazole: a pilot study assessing safety and approaches to appropriate management. Pharmacotherapy 28:719–729
Marty FM, Lowry CM, Cutler CS, Campbell BJ, Fiumara K, Baden LR, Antin JH (2006) Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12:552–559
Mencarelli F, Marks SD (2012) Non-viral infections in children after renal transplantation. Pediatr Nephrol 27:1465–1476
Gavaldà J, Meije Y, Fortún J, Roilides E, Saliba F, Lortholary O, Muñoz P, Grossi P, Cuenca‐Estrella M (2014) Invasive fungal infections in solid organ transplant recipients. Clin Microbiol Infect 20:27–48
Singh N, Avery RK, Munoz P, Pruett TL, Alexander B, Jacobs R, Tollemar JG, Dominguez EA, Chen MY, Paterson DL, Husain S (2003) Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 36:46–52
Soubani AO, Chandrasekar PH (2002) The clinical spectrum of pulmonary aspergillosis. Chest 121:1988–1999
Altiparmak MR, Apaydin S, Trablus S, Serdengecti K, Ataman R, Ozturk R, Erek E (2002) Systemic fungal infections after renal transplantation. Scand J Infect Dis 34:284–288
López-Medrano F, Silva JT, Fernández-Ruiz M, Carver PL, van Delden C, Merino E, Pérez-Saez MJ, Montero M, Coussement J, de Abreu MM, Cervera C, Santos L, Sabé N, Scemla A, Cordero E, Cruzado-Vega L, Martín PL, Len Ó, Rudas E, Ponce de León A, Arriola M, Lazurica R, David M, González-Rico C, Henríquez-Palop F, Fortún J, Nucci M, Manuel O, Paño-Pardo JR, Montejo M, Muñoz P, Sánchez-Sobrino B, Mazuecos A, Pascual J, Horcajada JP, Lecompte T, Lumbreras C, Moreno A, Carratalà J, Blanes M, Hernández D, Hernández-Méndez EA, Fariñas MD, Perelló-Carrascosa M, Morales JM, Andrés A, Aguado JM, Spanish Network for Research in Infectious Diseases REIPI, Group for the Study of Infection in Transplant Recipients (GESITRA), Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC), Study Group for Infections in Compromised Hosts (ESGICH), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Swiss Transplant Cohort Study (STCS) (2016) Risk factors associated with early invasive pulmonary aspergillosis in kidney transplant recipients: results from a multinational matched case–control study. Am J Transplant 16(7):2148–2157
American Academic of Pediatrics (2015) Antifungal drugs for systemic fungal infections. In: Kimberlin DW, Brady MT, Jackson MA, Long SS (eds) Red Book: Report of the Committee on Infectious Disease, 30th edn, Elk Grove Village, p 765–772
Singh N, Husain S (2009) Invasive aspergillosis in solid organ transplant recipients. Am J Transplant 9:S180–S191
Ambasta A, Carson J, Church DL (2015) The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients. Med Mycol 53:531–557
Hope WW, Walsh TJ, Denning DW (2005) Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 5:609–622
Blum U, Windfuhr M, Buitrago-Tellez C, Sigmund G, Herbst EW, Langer M (1994) Invasive pulmonary aspergillosis: MRI, CT, and plain radiographic findings and their contribution for early diagnosis. Chest 106:1156–1161
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to disclose
Additional information
This refers to the article that can be found at doi: 10.1007/s00467-016-3453-y.
Rights and permissions
About this article
Cite this article
Kakajiwala, A., Fernandes, P., Pawel, B.R. et al. The ‘hole’ story of a lung: Answers. Pediatr Nephrol 32, 777–779 (2017). https://doi.org/10.1007/s00467-016-3454-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-016-3454-x